Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Bioregulators · Dosing reference

Chonluten dosage

What the human evidence does and does not show, how long studies ran, and the arithmetic for working with vials.

Not approved — research use onlyDMechanistic onlyNone established
Full research pageCycle-length evidenceComparePrefer Amiravo on Google
Regulatory status
Not approved — research use only
Human amounts
None established in humans
Route studied
—
Frequency
Not established
Half-life
Not established
Evidence grade
Grade D · Mechanistic only
Vial sizes on the market
20 mg
Other forms seen
—

What Chonluten is

A short bioregulator peptide associated with lung and bronchial tissue, investigated in laboratory research on tissue-specific regulation.

Only one mechanistic data set was identified. In the human THP-1 monocyte/macrophage line differentiated with phorbol ester, Chonluten was one of five peptides reported to increase tyrosine phosphorylation of mitogen-activated cytoplasmic kinases, and to reduce expression of TNF and interleukin-6 induced by bacterial lipopolysaccharide 1. The authors reported that the peptide on its own caused a slight release of… How it works →

Key evidence

  • Avolio et al., International Journal of Molecular Sciences · 2022 · Cells (human THP-1 monocyte/macrophage leukaemia line, PMA-differentiated; adhesion assay on LPS-activated HUVECs)
    All five peptides were reported to reduce LPS-stimulated TNF and IL-6 expression and to reduce THP-1 adhesion to activated endothelium. Chonluten specifically was reported to inhibit TNF production by LPS-exposed monocytes, to activate STAT1 phosphorylation, and to be the only peptide clearly increasing apoptosis, roughly doubling the apoptotic value relative to the others. This is the only peer-reviewed study identified under this compound name. 1
All studies on the research page

What the human evidence shows

No approved or established human dose

We searched PubMed and ClinicalTrials.gov and found no human studies that administered Chonluten. The research described on its page is from cells or animals, and animal amounts do not translate to people.

How long did human studies run?

No human study durations are recorded for Chonluten.

Cycle-length evidence for Chonluten

Chonluten draw calculator

Pick the vial strength and the water added, enter an amount, and see the concentration, the units to draw and how many draws the vial holds. Arithmetic only.

1 · Vial strength
sizes on the market
2 · Water added
3 · Amount per draw
4 · Syringe
Your mix
20 mg + 2 mL water = 10 mg/mL
10 units holds 1 mg
Draw toEnter an amount in step 3
0102030405060708090100
U-100 syringe · 100 units = 1 mL

Computed from your inputs. Not a dose or a recommendation.

Compare water volumes for this vialShow

More water = lower concentration = a larger, easier-to-measure draw. Tap a row to use it.

Watermg/mLDraw
0.5 mL40—
1 mL20—
1.5 mL13.33—
2 mL10—
2.5 mL8—
3 mL6.667—
5 mL4—

Supplies and handling

  • Lyophilized vial
    Sealed vial with the freeze-dried cake. Check the label, lot and the certificate of analysis before opening.
  • Sterile diluent
    The diluent named on the product documentation. Bacteriostatic water contains benzyl alcohol; sterile water does not.
  • Graduated syringes
    Sized to the volume being measured. U-100 insulin syringes are graduated in units where 100 units = 1 mL.
  • Alcohol prep pads
    For wiping vial stoppers before each puncture.
  • Nitrile gloves
    Clean gloves for aseptic handling.
  • Sharps container
    Puncture-resistant container for used needles.
Step-by-step reconstitution guideStorage and transport accessories

Storage

Handling should follow the certificate of analysis and written documentation supplied with the specific lot; no stability or handling data specific to this compound were identified in the sources reviewed. Short lyophilised peptides are generally treated as hygroscopic, light-sensitive solids whose reconstituted solutions are chemically less stable than the dry material. Amiravo does not provide preparation, reconstitution or administration instructions.

  • Lyophilized (unmixed) vials: typically stored cold and dry, away from light, as the documentation directs. Many are stable longer frozen.
  • Reconstituted vials: typically refrigerated (about 2–8 °C), protected from light and not frozen.
  • Bacteriostatic water contains benzyl alcohol, which inhibits bacterial growth in multi-use vials; sterile water has no preservative.

Handling mistakes and troubleshooting

Added the wrong volume of diluent
The concentration changes, not the amount of compound in the vial. Recalculate with the volume actually added and relabel the vial.
Shook the vial and it foamed
Let it settle in the refrigerator. Foam is a sign of agitation; some peptides aggregate when shaken. Note it on the label.
The solution is cloudy or has particles
Do not use it. Cloudiness can indicate incomplete dissolution, contamination or degradation. Record the lot and contact the supplier with the certificate of analysis.
The powder cake looks melted or shrunken before reconstitution
This can indicate the vial was exposed to heat or moisture. Record the lot and condition on arrival.
Liquid sprayed back when the needle was removed
Pressure built up in the vial. Withdraw a small volume of air while adding diluent to keep pressure neutral.

Regulatory status

Status
Not approved by the FDA for any use; no human drug labeling matching this name was returned by the openFDA Drug Label API 7.
United States (FDA)
There is no approved FDA application for this peptide; an openFDA Drug Label API query returned no matching human drug labeling 7. Neither "chonluten" nor "Glu-Asp-Gly" appears in any of the three categories of FDA's list of bulk drug substances nominated for use in compounding under section 503A of the FD&C Act, as updated 14 May 2026 8.
Sport (WADA)
Not named in the WADA 2026 Prohibited List 9. That absence is hedged negative evidence and not a clearance. Section S0 prohibits at all times "any pharmacological substance which is not currently approved by any governmental regulatory health authority for human therapeutic use" and states that the class "covers many different substances including but not limited to" its named examples; section S2 prohibits the listed peptide hormones, growth factors and mimetics "and other substances with similar chemical structure or similar biological effect(s)" 9.

Status varies by country and changes over time. How we describe regulatory status.

Chonluten compared with related compounds

CompoundStatusEvidenceHuman amountsHalf-life
ChonlutenNot approved — research use onlyDNone established—
TestagenNot approved — research use onlyDNone established—
CartalaxNot approved — research use onlyDNone established—
CortagenNot approved — research use onlyCNone established—
PinealonNot approved — research use onlyCNone established—
ThymalinNot approved — research use onlyBNone established—

Frequently asked questions

What doses of Chonluten have been studied in humans?
None that establish an amount. Chonluten is not approved anywhere and we found no human studies that administered it. Amiravo does not publish community or vendor figures.
Is there an established Chonluten cycle length?
No. We found no human studies that report treatment duration for Chonluten.
How much bacteriostatic water should be added to a Chonluten vial?
There is no compound-specific volume. The diluent volume only sets the concentration: concentration = mass in the vial ÷ volume added (for example, 10 mg in 2 mL gives 5 mg/mL). The calculator on this page shows the arithmetic for any combination.
How many units is a given amount on an insulin syringe?
On a U-100 syringe, 100 units = 1 mL. Units for an amount = amount ÷ (concentration per unit). The calculator converts any amount you enter at the concentration you choose; a unit is a volume mark, not an amount of compound.
Is Chonluten FDA-approved?
Not approved — research use only. Not approved by the FDA for any use; no human drug labeling matching this name was returned by the openFDA Drug Label API 7.

References

  1. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line International Journal of Molecular Sciences. 2022
  2. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line — full text, Section 4.1 Materials (peptide sequences) International Journal of Molecular Sciences (MDPI, open access). 2022
  3. PubMed query for "chonluten" (1 record) PubMed / NCBI Entrez (U.S. National Library of Medicine). 2026
  4. PubChem compound name lookup for "Chonluten" (PUGREST.NotFound — no CID) PubChem, U.S. National Library of Medicine. 2026
  5. MeSH / NCBI Entrez query for "chonluten" (0 records) Medical Subject Headings, U.S. National Library of Medicine. 2026
  6. ClinicalTrials.gov registry query for "chonluten" (0 studies returned) ClinicalTrials.gov (U.S. National Library of Medicine). 2026
  7. openFDA Drug Label API query for "chonluten" (no approved human drug labeling for a peptide of this name) U.S. Food and Drug Administration / openFDA. 2026
  8. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026) U.S. Food and Drug Administration. 2026
  9. World Anti-Doping Code International Standard — Prohibited List 2026 (effective 1 January 2026) World Anti-Doping Agency. 2026

Last reviewed October 23, 2026 by the Amiravo editorial team. Editorial policy · Report an error